Voyager Therapeutics

Neurocrine hands back 2 CNS gene therapy programs to Voyager

Neurocrine handed back two discovery-stage gene therapy programs to Voyager, although the companies’ wider CNS-focused collaboration remains on track.

James Waldron May 7, 2025 7:30am

Voyager's ALS program delayed by search for alternative payload

Feb 11, 2025 10:27am

Novartis ignites new stage of Voyager pact with $15M capsid deal

Sep 5, 2024 9:45am

Fierce 15: Where are they now?

Jul 26, 2024 6:50am

Another Biogen exec hitches ride to Voyager —Chutes & Ladders

Mar 15, 2024 9:30am

rocket launch satellite space fly blast off

Novartis, Voyager launch $100M gene therapy mission

Jan 2, 2024 8:31am